SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-001190
Filing Date
2013-05-08
Accepted
2013-05-07 21:28:47
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cpix2013331-10q.htm 10-Q 411644
2 EX-31.1 cpix2013331-exhibit311.htm EX-31.1 15946
3 EX-31.2 cpix2013331-exhibit312.htm EX-31.2 15955
4 EX-32.1 cpix2013331-exhibit321.htm EX-32.1 8104
  Complete submission text file 0001445305-13-001190.txt   2785463

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20130331.xml EX-101.INS 306399
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20130331.xsd EX-101.SCH 26205
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20130331_cal.xml EX-101.CAL 45128
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20130331_def.xml EX-101.DEF 129297
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20130331_lab.xml EX-101.LAB 314647
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20130331_pre.xml EX-101.PRE 169014
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 13822109
SIC: 2834 Pharmaceutical Preparations